Thrombin Inhibits Tumor Cell Growth in Association with Up-regulation of p21 and Caspases via a p53-independent, STAT-1-dependent Pathway
Open Access
- 1 March 2000
- journal article
- Published by Elsevier
- Vol. 275 (9), 6462-6468
- https://doi.org/10.1074/jbc.275.9.6462
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Molecular Mechanisms of Angiotensin II in Modulating Cardiac Function: Intracardiac Effects and Signal Transduction PathwaysJournal of Molecular and Cellular Cardiology, 1997
- The Cloned Thrombin Receptor Is Necessary and Sufficient for Activation of Mitogen-activated Protein Kinase and Mitogenesis in Mouse Lung FibroblastsPublished by Elsevier ,1996
- Ligand Cross-reactivity within the Protease-activated Receptor FamilyJournal of Biological Chemistry, 1996
- Thrombin receptor activation elicits rapid protein tyrosine phosphorylation and stimulation of the raf-1/MAP kinase pathway preceding delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for an obligate autocrine mechanism promoting cell proliferation induced by G-protein-coupled receptor agonist.Journal of Clinical Investigation, 1996
- Thrombin Receptor Activating Mutations: ALTERATION OF AN EXTRACELLULAR AGONIST RECOGNITION DOMAIN CAUSES CONSTITUTIVE SIGNALINGPublished by Elsevier ,1996
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994
- Phosphorylation of JAK2 in thrombin‐stimulated human plateletsFEBS Letters, 1994
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- Thrombin stimulates melanoma tumor‐cell binding to endothelial cells and subendothelial matrixInternational Journal of Cancer, 1993
- Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activationCell, 1991